HC Wainwright & Co. Reiterates Buy on Sensus Healthcare, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Sensus Healthcare (NASDAQ:SRTS) and maintained a $10 price target.
August 12, 2024 | 9:39 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Sensus Healthcare and maintained a $10 price target.
The reiteration of a Buy rating and the maintenance of a $10 price target by HC Wainwright & Co. is a positive signal for investors, likely boosting short-term confidence and potentially driving the stock price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100